2Takahash i K,N agata H,Kitao M,et al.Clinieal usefulness of detem ination of estradio level in the menstrual blood for patients with endometriosis.Acta Obset Gynecal Jpn,1989,41(12):1849-1850.
3Noble L S,Simp son ER,Johns A,et al.Aromatase expression in endometrosis[J]. Clin Endocrino Metab,1996,81(1):174-179.
5Fang Z,Yang S,Gurates B,et al.Genetic or enzymatic dis-ruption of aromatase inhibits the growth of ectopic uterine tissue [J].J Clin Endocrinol Metab ,2002,87 (7):3460-3466.
6Meresman GF,Bilotas M,Abello V,et al.Effects of aromatase inhibitors on proliferation and apoptosis in eutopic eudo-metrial cell cultures from patients with endometriosis [J] . Fertil Steril,2005,84(2):459-463.
7Takayama K,Zeitoun K,Gunby R T,et al.Treatment of severe postmenopausal endometriosis with an aromatase inhibitor [J].Fertil Steril,1998,69(4):709-713.
8Amsterdam L,Gentry W,Jobanputra S, et al.Anastrazole and oral contracep tives:a novel treatment for endometriosis[J]. Fertil Steril,2005,84(2):300-304.
9Ota H,Igarashi S,Sasaki M,et al.Distribution of cycloo-genase-2 in eutopic and ectopic endometrium in endometrio-sis and adenomyosis [J].Hum Reprod,2001,6 (3):561-566.
1Kudoh M, Susaki Y, Ideyama Y, et al. Inhibitory effects of a novel aromatase inhibitor, YM511, on growth of endometrial explants and insulin-like growth factor- I gene expression in rats with experimental endometriosis. J Steroid Biochem Mol Biol, 1997, 63(1-3):75-80.
2Yano S ,Ikegami Y, Nakao K, et al .Studies on the effect of the new non-steroidal aromatase inhibitor fadrozole hydrochloride in an endometriosis model in rats. Arzneimittelforschung,1996, 46(2): 192-5.
3Thiantanawat A, Long B J, Brodie AM, et al. Singaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens. Cancer Res, 2003, 63(22): 8 037-50.
4Sasano H, Sato S, Ito K, et al. Effects of aromatase inhibitors on the pathobiology of the human breast,endometrial and ovarian carcinoma. Endocr Relat Cancer, 1999, 6(2): 197-204.
5Bulun SE, Zeitoun K, Takayama K, et al. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endo Rel Cancer, 1999, 6(2):293-301.
6Leahy KM, Omberg RL, Wang Y, et al. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res,2002, 62(3): 625-31.
7Sheng H, Shao J, Dubois RN, et al. Inhibition of human colon cancer cell growth by selective inhibition of COX-2. J Clin Invest, 1997, 99(9): 2 254-9.
8Jones RC. The effect of a luteinizing hormone releasing hormone (LRH)agonist(Wy-40,972),levohorgestrel,dan azol and ovariectomy on experimental endometriosis in the rat.Acta Endocrinol, 1984, 106(2): 282-6.
9FangZ, YangS,TamuraM,etal. Genetic or enzymaticdisruption of aromatase inhibits the growth of ectopic uterine tissue. J Clin Endocrinol Metab, 2002, 87(7): 3 460-6.
10Hickey GJ & Richards JS. Hormonal regulation, tissue distribution and content of aromatase cytochrome P450 messenger ribonucleic acid and enzyme in rat ovarian follicles and corpora lutea: relationship to estradiol biosynthesis.Endocrinology, 1988, 122(4): 1 426-36.
